Form C/A — Deverra Therapeutics, Inc.
0001665160-24-000559 · filed Apr 26, 2024
· via StartEngine Capital, LLC
Offering
- Target
- $14,999
- Maximum
- $1,234,999
- Security type
- Common Stock
- Price per security
- $2.0900
- Deadline
- —
- Oversubscription
- Accepted
Issuer
- CIK
- 1822782
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 2033 6th Ave Suite 600
Seattle, WA 28121 - Phone
- —
Most recent fiscal year financials
- Total assets
- $7,153,624
- Cash
- —
- Short-term debt
- $7,222,643
- Long-term debt
- —
- Revenues
- $1,677,259
- COGS
- $1,677,259
- Taxes paid
- —
- Net income
- $1,672,096
View the original filing on SEC EDGAR ↗